Hypothesis 1: Typographical Error
The identifier "SPCC4F11.04c" does not conform to standard antibody naming conventions (e.g., "scFv-FcC21" , "N6" , or "nirsevimab" ). It may represent a typographical error or internal laboratory code not yet published.
Hypothesis 2: Undisclosed or Proprietary Compound
The term could denote a confidential or early-stage research antibody not disclosed in public databases. For example, antibodies like 6D3 and 4A8 (targeting SARS-CoV-2) were initially described in niche contexts before broader publication .
While "SPCC4F11.04c" remains unidentified, the search results highlight antibodies with analogous naming structures or therapeutic roles:
Verify Nomenclature: Cross-check identifiers with repositories like the Antibody Registry (https://antibodyregistry.org) or UniProt.
Explore Patent Databases: Investigate pending patents for proprietary antibodies (e.g., USPTO, WIPO).
Contact Authors: Reach out to researchers specializing in antibody engineering (e.g., teams behind , , or ).
KEGG: spo:SPCC4F11.04c
STRING: 4896.SPCC4F11.04c.1
SPCC4F11.04c is a gene that encodes a mannosyl transferase in Schizosaccharomyces pombe. Mannosyl transferases catalyze the transfer of mannose residues during protein glycosylation processes. In S. pombe, this enzyme is particularly significant for cell wall formation and integrity. Based on homology studies, SPCC4F11.04c appears related to proteins involved in β-1,6-glucan synthesis pathways, which are essential for fungal cell wall structure .
The protein encoded by SPCC4F11.04c likely functions in the post-Golgi vesicles or late Golgi apparatus, consistent with other glycosylation enzymes. Research into this protein provides insights into fundamental cellular processes including protein modification, cell wall biogenesis, and membrane trafficking in eukaryotic systems.
SPCC4F11.04c antibodies can support multiple research applications:
Western blot analysis for protein expression and modification studies
Immunoprecipitation for protein complex isolation
Immunofluorescence microscopy for subcellular localization
Proteomic analyses of glycosylation pathways
Cell wall composition studies
Functional characterization of protein glycosylation networks
These applications collectively enable comprehensive investigation of SPCC4F11.04c's roles in cellular processes, particularly those related to protein glycosylation and cell wall formation.
Generating specific antibodies against SPCC4F11.04c requires careful consideration of several factors:
| Approach | Advantages | Considerations |
|---|---|---|
| Peptide immunization | Targets specific epitopes, cost-effective | May miss conformational epitopes |
| Recombinant protein immunization | Recognizes native structure, higher specificity | More complex production process |
| GST-fusion peptides | Enhanced immunogenicity, simplified purification | May introduce non-specific responses |
| Affinity purification | Increases specificity, reduces background | Additional processing required |
For SPCC4F11.04c specifically, using GST-fusion peptides has been demonstrated as an effective approach for generating polyclonal antibodies with sufficient specificity for research applications . The selection of unique, non-conserved epitopes is crucial for preventing cross-reactivity with other mannosyl transferases.
Comprehensive validation should include:
Western blot analysis comparing wild-type and sup11-depleted strains
Immunoprecipitation followed by mass spectrometry confirmation
Peptide competition assays to verify epitope-specific binding
Cross-reactivity testing against related proteins
Validation across multiple experimental conditions and applications
Researchers should document band patterns, molecular weights, and subcellular distribution patterns to establish reliable validation criteria. For transmembrane proteins like SPCC4F11.04c, additional validation through proteinase K protection assays can verify topology predictions .
For accurate subcellular localization:
Cell preparation: Optimize spheroplasting procedures using enzymatic digestion (lysing enzymes) to maintain cellular integrity while ensuring antibody accessibility.
Fixation: Compare paraformaldehyde and methanol fixation to determine optimal epitope preservation.
Controls: Include both negative controls (pre-immune serum) and positive controls (co-staining with known Golgi/ER markers).
Membrane protein considerations: Use detergent concentrations appropriate for transmembrane proteins.
Signal verification: Confirm specificity through parallel experiments with GFP-tagged constructs (C-terminal or N-terminal tagging, depending on topology) .
Analysis should include co-localization studies with organelle markers, particularly those for the Golgi apparatus and post-Golgi vesicles, where glycosylation enzymes typically reside.
Native SPCC4F11.04c isolation requires specialized approaches:
Membrane protein extraction using detergent solubilization (Triton X-100, NP-40, or digitonin)
Sucrose density gradient centrifugation for subcellular fractionation
Immunoprecipitation using validated antibodies
Affinity chromatography for tagged versions of the protein
Size exclusion chromatography to separate protein complexes
Researchers should note that membrane protein isolation often requires optimization of detergent type and concentration to maintain native conformations. For SPCC4F11.04c specifically, successful isolation has been achieved through sucrose gradient fractionation methods coupled with detergent extraction .
To investigate SPCC4F11.04c's functional role:
Gene depletion studies: Utilize nmt81-regulated expression systems to control protein levels
Cell wall component analysis: Measure β-1,6-glucan content in control vs. SPCC4F11.04c-depleted cells
Glycoprotein profiling: Analyze glycoprotein composition using PAS-Silver staining techniques
Genetic interaction studies: Test interactions with other glycosylation pathway components
Transcriptome analysis: Identify downstream effects on cell wall genes and glycosylation pathways
Research has shown that Sup11p (encoded by SPCC4F11.04c) significantly impacts β-1,6-glucan synthesis, with depletion resulting in complete absence of this cell wall component . This suggests a key regulatory or catalytic role in cell wall biogenesis pathways.
Distinguishing primary from secondary effects requires multiple approaches:
Time-course analysis: Monitor changes following conditional depletion to identify earliest effects
Genetic suppressor screens: Identify genes that can compensate for SPCC4F11.04c deficiency
Domain mutation studies: Create specific functional domain mutations to isolate functions
Complementation experiments: Test rescue with wild-type vs. mutant constructs
Comparative analysis: Contrast effects with other mannosyl transferase mutants
Research has demonstrated that SPCC4F11.04c depletion affects glycosylation pathways, septum formation, and cell wall integrity . Careful experimental design is essential to distinguish which effects represent direct consequences of protein absence versus downstream cellular responses.
To improve antibody specificity:
| Problem | Solution Strategy | Implementation Details |
|---|---|---|
| Multiple bands in Western blot | Antibody purification | Affinity purification against GST-fusion peptides of Sup11p |
| High background | Optimization of blocking | Test various blocking agents; BSA has shown better results than milk proteins |
| Cross-reactivity | Pre-absorption | Pre-incubate antibody with lysates from deletion strains |
| Variable results | Standardized protocols | Establish consistent sample preparation and antibody dilution protocols |
When working with membrane proteins like SPCC4F11.04c, additional considerations include optimizing detergent concentrations and ensuring complete solubilization without disrupting epitope accessibility .
Detection sensitivity depends on:
Protein expression levels: SPCC4F11.04c may be expressed at relatively low levels, requiring signal amplification methods
Post-translational modifications: Glycosylation status affects antibody binding and protein mobility
Subcellular localization: Membrane localization necessitates appropriate extraction methods
Protein topology: Transmembrane orientation influences epitope accessibility
Experimental conditions: Buffer composition, pH, and detergent selection significantly impact detection
Research has shown that SPCC4F11.04c is subject to O-mannosylation, which affects both protein stability and detection characteristics in experimental systems . Researchers should consider these modifications when interpreting experimental results.
When facing contradictory results:
Epitope mapping: Determine which protein regions each antibody recognizes
Validation comparison: Assess the validation rigor for each antibody preparation
Functional domain awareness: Consider whether antibodies target catalytic or regulatory domains
Post-translational modification sensitivity: Test whether glycosylation affects antibody recognition
Application-specific optimization: Evaluate whether antibodies perform differently across applications
For robust statistical analysis:
Establish appropriate normalization controls (housekeeping proteins stable under experimental conditions)
Perform power analyses to determine required sample sizes
Apply appropriate statistical tests based on data distribution (parametric vs. non-parametric)
Use multiple comparison corrections when analyzing complex datasets
Incorporate biological replicates to account for natural variation
Consider bayesian approaches for integrating diverse data types
When analyzing SPCC4F11.04c expression or functional data, researchers should consider the inherent variability in membrane protein extraction and the impact of cell wall integrity on experimental consistency.
For protein interaction studies:
Co-immunoprecipitation with SPCC4F11.04c antibodies followed by mass spectrometry
Proximity labeling approaches (BioID, APEX) to identify proteins in close proximity
Blue native PAGE to preserve native protein complexes
Crosslinking mass spectrometry to capture transient interactions
Two-hybrid screening to identify direct binding partners
Research has shown that mannosyl transferases often function in multi-protein complexes within the secretory pathway. SPCC4F11.04c likely participates in such complexes during cell wall biogenesis and glycosylation processes .
Evolutionary studies can be approached through:
Cross-species immunoblotting to test antibody recognition of homologous proteins
Comparative localization studies across fungal species
Functional complementation experiments with homologs from other organisms
Epitope conservation analysis across fungal and other eukaryotic species
Structural analysis of conserved domains recognized by antibodies
SPCC4F11.04c shows significant homology to Saccharomyces cerevisiae Kre9, which is involved in β-1,6-glucan synthesis, suggesting evolutionary conservation of this glycosylation function across fungal species . Antibodies recognizing conserved epitopes could provide valuable tools for comparative studies.